Target intelligence / Profile preview

Uropathogenic Escherichia coli outer membrane and cell surface (UPEC OM)

Target
UPEC OM
Molecular classification
Bacterial outer membrane, Cell surface complex, Lipopolysaccharide-protein complex
01

Overview

The uropathogenic Escherichia coli (UPEC) outer membrane and cell surface constitute a multifaceted structural and functional barrier essential for the survival and virulence of UPEC within the urinary tract [1]. This surface is characterized by a diverse array of virulence factors, including adhesins like FimH (Type 1 fimbriae) and PapG (P fimbriae), which mediate attachment to the bladder and kidney epithelium, respectively [2][3]. The outer membrane also contains lipopolysaccharides (LPS) and various outer membrane proteins (OMPs) that contribute to structural integrity, nutrient acquisition, and evasion of the host's innate immune system [4]. From a therapeutic perspective, this surface is a high-value target; polymyxin antibiotics act by binding to LPS and disrupting membrane stability, while emerging anti-adhesive therapies aim to block bacterial colonization without exerting the selective pressure of traditional bactericidal agents [5][6]. Furthermore, the surface-exposed components are the primary focus for vaccine development, seeking to elicit antibodies that neutralize the bacteria before they can establish an infection [7]. Sources: [1] PMC3357104; [2] PubMed 22561066; [3] Nature Reviews Microbiology 17, 297–311 (2019); [4] PMC4415365; [5] Frontiers in Microbiology 11, 1426 (2020); [6] Microbiology Society; [7] PubChem CID 5360371.

Other names
UPEC cell surfaceUPEC outer membraneUropathogenic E. coli cell envelopeUPEC surface antigens
02

Mechanism of action

Disruption of bacterial outer membrane integrity, inhibition of bacterial adhesion to host cells, and neutralization of surface-exposed virulence factors.

03

Biological functions

Bacterial adhesionHost cell colonizationImmune system evasionMembrane transportStructural maintenance
04

Disease associations

InfectionUrinary tract infectionCystitisPyelonephritisUrosepsis
05

Safety considerations

NephrotoxicityNeurotoxicityDevelopment of antimicrobial resistanceAlteration of the host microbiome
06

Interacting drugs

Polymyxin B

3 more in the full profile.

07

Biomarkers

UPEC O-antigenFimH adhesin expressionP-fimbriae presence

Beyond the preview

Go deeper on Uropathogenic Escherichia coli outer membrane and cell surface (UPEC OM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uropathogenic Escherichia coli outer membrane and cell surface (UPEC OM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call